{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:50:28Z","timestamp":1785199828804,"version":"3.55.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31501171"],"award-info":[{"award-number":["31501171"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31571433"],"award-info":[{"award-number":["31571433"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773131"],"award-info":[{"award-number":["81773131"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003995","name":"Anhui Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["1608085MH180"],"award-info":[{"award-number":["1608085MH180"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003995","name":"Anhui Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["1508085SMC214"],"award-info":[{"award-number":["1508085SMC214"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004739","name":"Youth Innovation Promotion Association of Chinese Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004739","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.bbrc.2018.02.010","type":"journal-article","created":{"date-parts":[[2018,2,13]],"date-time":"2018-02-13T20:14:30Z","timestamp":1518552870000},"page":"1322-1330","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["The melatonin-MT1 receptor axis modulates tumor growth in PTEN-mutated gliomas"],"prefix":"10.1016","volume":"496","author":[{"given":"Huihui","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangrong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenggang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyou","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7690-4749","authenticated-orcid":false,"given":"Xueran","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2018.02.010_bib1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3171\/jns.1988.68.1.0085","article-title":"Gliomas of the optic nerve or chiasm. Outcome by patients' age, tumor site, and treatment","volume":"68","author":"Alvord","year":"1998","journal-title":"J.\u00a0Neurosurg."},{"key":"10.1016\/j.bbrc.2018.02.010_bib2","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0889-8588(05)70263-X","article-title":"Molecular biology of nervous system tumors","volume":"15","author":"Rempel","year":"2001","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"10.1016\/j.bbrc.2018.02.010_bib3","first-page":"207","article-title":"Molecular biology of glioma tumorigenesis","volume":"18","author":"Ware","year":"2003","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.bbrc.2018.02.010_bib4","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/386470","article-title":"Newcastle disease virus interaction in targeted therapy against proliferation and invasion pathways of glioblastoma multiforme","volume":"2014","author":"Abdullah","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.bbrc.2018.02.010_bib5","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5732\/cjc.013.10217","article-title":"Radiotherapy of high-grade gliomas: current standards and new concepts, innovations in imaging and radiotherapy, and new therapeutic approaches","volume":"33","author":"Dhermain","year":"2014","journal-title":"Chin. J. Canc."},{"key":"10.1016\/j.bbrc.2018.02.010_bib6","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5732\/cjc.013.10217","article-title":"Radiotherapy of high-grade gliomas: current standards and new concepts, innovations in imaging and radiotherapy, and new therapeutic approaches","volume":"33","author":"Dhermain","year":"2014","journal-title":"Chin. J. Canc."},{"key":"10.1016\/j.bbrc.2018.02.010_bib7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1210\/edrv-12-2-151","article-title":"Pineal melatonin: cell biology of its synthesis and of its physiological interactions","volume":"12","author":"Reiter","year":"1991","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bbrc.2018.02.010_bib8","doi-asserted-by":"crossref","first-page":"C153","DOI":"10.1016\/0303-7207(91)90087-9","article-title":"Melatonin: the chemical expression of darkness","volume":"79","author":"Reiter","year":"1991","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbrc.2018.02.010_bib9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1600-079X.2011.00931.x","article-title":"Extrapineal melatonin: analysis of its subcellular distribution and daily fluctuations","volume":"52","author":"Venegas","year":"2012","journal-title":"J.\u00a0Pineal Res."},{"key":"10.1016\/j.bbrc.2018.02.010_bib10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1034\/j.1600-079X.2002.2e001.x","article-title":"Role of CSF in the transport of melatonin","volume":"33","author":"Reiter","year":"2002","journal-title":"J.\u00a0Pineal Res."},{"key":"10.1016\/j.bbrc.2018.02.010_bib11","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1007\/s00018-008-8001-x","article-title":"Melatonin, hormone of darkness and more: occurrence, control mechanisms, actions and bioactive metabolites","volume":"65","author":"Hardeland","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbrc.2018.02.010_bib12","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/jpi.12075","article-title":"The role of melatonin in the cells of the innate immunity: a review","volume":"55","author":"Calvo","year":"2013","journal-title":"J.\u00a0Pineal Res."},{"key":"10.1016\/j.bbrc.2018.02.010_bib13","doi-asserted-by":"crossref","first-page":"R183","DOI":"10.1530\/ERC-15-0030","article-title":"Melatonin: an inhibitor of breast cancer","volume":"22","author":"Hill","year":"2015","journal-title":"Endocr. Relat. Canc."},{"key":"10.1016\/j.bbrc.2018.02.010_bib14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1600-079X.2011.00915.x","article-title":"New paradigms in chronic intestinal inflammation and colon cancer: role of melatonin","volume":"51","author":"Motilva","year":"2011","journal-title":"J.\u00a0Pineal Res."},{"key":"10.1016\/j.bbrc.2018.02.010_bib15","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/jpi.12227","article-title":"Melatonin as a treatment for gastrointestinal cancer: a review","volume":"58","author":"Xin","year":"2015","journal-title":"J.\u00a0Pineal Res."},{"key":"10.1016\/j.bbrc.2018.02.010_bib16","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1158\/0008-5472.CAN-05-2354","article-title":"Intracellular signaling pathways involved in the cell growth inhibition of glioma cells by melatonin","volume":"66","author":"Martin","year":"2006","journal-title":"Canc. Res."},{"key":"10.1016\/j.bbrc.2018.02.010_bib17","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1600-079X.2012.00985.x","article-title":"Melatonin suppresses migration and invasion via inhibition of oxidative stress pathway in glioma cells","volume":"53","author":"Wang","year":"2012","journal-title":"J.\u00a0Pineal Res."},{"key":"10.1016\/j.bbrc.2018.02.010_bib18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/jpi.12052","article-title":"Melatonin antagonizes hypoxia-mediated glioblastoma cell migration and invasion via inhibition of HIF-1alpha","volume":"55","author":"Zhang","year":"2013","journal-title":"J.\u00a0Pineal Res."},{"key":"10.1016\/j.bbrc.2018.02.010_bib19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/excr.2000.5130","article-title":"PTEN: life as a tumor suppressor","volume":"264","author":"Simpson","year":"2001","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbrc.2018.02.010_bib20","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1007\/s00018-017-2500-6","article-title":"PTEN proteoforms in biology and disease","volume":"74","author":"Malaney","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbrc.2018.02.010_bib21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12935-016-0290-9","article-title":"Tumor suppressor genes and their underlying interactions in paclitaxel resistance in cancer therapy","volume":"16","author":"Xu","year":"2016","journal-title":"Canc. Cell Int."},{"key":"10.1016\/j.bbrc.2018.02.010_bib22","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1215\/15228517-4-3-196","article-title":"Pten signaling in gliomas","volume":"4","author":"Knobbe","year":"2002","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.bbrc.2018.02.010_bib23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-3-319-12048-5_2","article-title":"Glioma biology and molecular markers","volume":"163","author":"Cohen","year":"2015","journal-title":"Canc. Treat Res."},{"key":"10.1016\/j.bbrc.2018.02.010_bib24","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1038\/sj.onc.1206388","article-title":"Loss of PTEN\/MMAC1\/TEP in EGF receptor-expressing tumor cells counteracts the antitumor action of EGFR tyrosine kinase inhibitors","volume":"22","author":"Bianco","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2018.02.010_bib25","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1517\/14728222.8.6.537","article-title":"The complexity of PTEN: mutation, marker and potential target for therapeutic intervention","volume":"8","author":"Steelman","year":"2004","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.bbrc.2018.02.010_bib26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ccr.2004.06.022","article-title":"PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients","volume":"6","author":"Nagata","year":"2004","journal-title":"Canc. Cell"},{"key":"10.1016\/j.bbrc.2018.02.010_bib27","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/jpi.12316","article-title":"Melatonin prevents cisplatin-induced primordial follicle loss via suppression of PTEN\/AKT\/FOXO3a pathway activation in the mouse ovary","volume":"60","author":"Jang","year":"2016","journal-title":"J.\u00a0Pineal Res."},{"key":"10.1016\/j.bbrc.2018.02.010_bib28","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/jpi.12316","article-title":"Melatonin prevents cisplatin-induced primordial follicle loss via suppression of PTEN\/AKT\/FOXO3a pathway activation in the mouse ovary","volume":"60","author":"Jang","year":"2016","journal-title":"J.\u00a0Pineal Res."},{"key":"10.1016\/j.bbrc.2018.02.010_bib29","doi-asserted-by":"crossref","first-page":"4998","DOI":"10.1158\/0008-5472.CAN-17-1139","article-title":"EZH2 palmitoylation mediated by ZDHHC5 in p53-mutant glioma drives malignant development and progression","volume":"77","author":"Chen","year":"2017","journal-title":"Canc. Res."},{"key":"10.1016\/j.bbrc.2018.02.010_bib30","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/jpi.12341","article-title":"Melatonin inhibits tumorigenicity of glioblastoma stem-like cells via the AKT-EZH2-STAT3 signaling axis","volume":"61","author":"Chen","year":"2016","journal-title":"J.\u00a0Pineal Res."},{"key":"10.1016\/j.bbrc.2018.02.010_bib31","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1046\/j.1365-2826.2001.00651.x","article-title":"Localization of the melatonin-related receptor in the rodent brain and peripheral tissues","volume":"13","author":"Drew","year":"2001","journal-title":"J.\u00a0Neuroendocrinol."},{"key":"10.1016\/j.bbrc.2018.02.010_bib32","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev-pharmtox-010814-124742","article-title":"MT1 and MT2 melatonin receptors: a therapeutic perspective","volume":"56","author":"Liu","year":"2016","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.bbrc.2018.02.010_bib33","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cell.2006.11.042","article-title":"Essential role for nuclear PTEN in maintaining chromosomal integrity","volume":"128","author":"Shen","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2018.02.010_bib34","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/j.celrep.2014.08.008","article-title":"PTEN interacts with histone H1 and controls chromatin condensation","volume":"8","author":"Chen","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbrc.2018.02.010_bib35","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11010-006-9371-8","article-title":"PTEN down regulates AP-1 and targets c-fos in human glioma cells via PI3-kinase\/Akt pathway","volume":"300","author":"Koul","year":"2007","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bbrc.2018.02.010_bib36","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1016\/j.jmb.2017.06.004","article-title":"Cell cycle control by PTEN","volume":"429","author":"Brandmaier","year":"2017","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.bbrc.2018.02.010_bib37","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1158\/0008-5472.CAN-16-2565","article-title":"Increased t-cell infiltration elicited by Erk5 deletion in a pten-deficient mouse model of prostate carcinogenesis","volume":"77","author":"Loveridge","year":"2017","journal-title":"Canc. Res."},{"key":"10.1016\/j.bbrc.2018.02.010_bib38","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s00432-017-2415-5","article-title":"Combinatorial therapy with adenoviral-mediated PTEN and a PI3K inhibitor suppresses malignant glioma cell growth in\u00a0vitro and in\u00a0vivo by regulating the PI3K\/AKT signaling pathway","volume":"143","author":"Nan","year":"2017","journal-title":"J.\u00a0Canc. Res. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2018.02.010_bib39","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jep.2016.12.051","article-title":"Apoptosis induced by the methanol extract of Salvia miltiorrhiza Bunge in non-small cell lung cancer through PTEN-mediated inhibition of PI3K\/Akt pathway","volume":"200","author":"Ye","year":"2017","journal-title":"J.\u00a0Ethnopharmacol."},{"key":"10.1016\/j.bbrc.2018.02.010_bib40","first-page":"1031","article-title":"Evaluation of the antiperoxidative effects of melatonin in ammonium acetate-treated Wistar rats","volume":"55","author":"Lena","year":"2003","journal-title":"Pol. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2018.02.010_bib41","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/S0024-3205(97)00030-1","article-title":"Pharmacological actions of melatonin in oxygen radical pathophysiology","volume":"60","author":"Reiter","year":"1997","journal-title":"Life Sci."},{"key":"10.1016\/j.bbrc.2018.02.010_bib42","first-page":"636","article-title":"Effects of melatonin on the levels of antioxidants and lipid peroxidation products in rats treated with ammonium acetate","volume":"59","author":"Lena","year":"2004","journal-title":"Pharmazie"},{"key":"10.1016\/j.bbrc.2018.02.010_bib43","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/bph.12457","article-title":"Melatonin MT(1) and MT(2) receptors display different molecular pharmacologies only in the G-protein coupled state","volume":"171","author":"Legros","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2018.02.010_bib44","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1600-079X.2011.00932.x","article-title":"Evidence that membrane-bound G protein-coupled melatonin receptors MT1 and MT2 are not involved in the neuroprotective effects of melatonin in focal cerebral ischemia","volume":"52","author":"Kilic","year":"2012","journal-title":"J.\u00a0Pineal Res."},{"key":"10.1016\/j.bbrc.2018.02.010_bib45","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.yebeh.2017.01.020","article-title":"Altered MT1 and MT2 melatonin receptors expression in the hippocampus of pilocarpine-induced epileptic rats","volume":"71","author":"Rocha","year":"2017","journal-title":"Epilepsy Behav."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X1830233X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X1830233X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T19:00:12Z","timestamp":1570734012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X1830233X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0006291X1830233X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.02.010","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The melatonin-MT1 receptor axis modulates tumor growth in PTEN-mutated gliomas","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}